HEMOSOL LG4
HEMOSOL LG4
Discontinued
DIN Number
02230505
Drug Class
Human
Market Date
Feb 20, 1997
Company
HC
gambro inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230505
AIG Number0652689002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05ZA HEMODIALYTICS, CONCENTRATES
Product Specifications
Dosage FormSolution
Route of AdministrationHaemodialysis
AHFS Classification40:34.00*
Health Canada Classification
ACTIVE INGREDIENTS (6)
CALCIUM CHLORIDEActive
Strength: 0.257 G / L
Monograph: CALCIUM CHLORIDE
DEXTROSE ANHYDROUS (DEXTROSE)Active
Strength: 1.1 G / L
Monograph: DEXTROSE ANHYDROUS (DEXTROSE)
MAGNESIUM CHLORIDEActive
Strength: 0.152 G / L
Monograph: MAGNESIUM CHLORIDE
POTASSIUM CHLORIDEActive
Strength: 0.298 G / L
Monograph: POTASSIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 5.844 G / L
Monograph: SODIUM CHLORIDE
SODIUM LACTATEActive
Strength: 4.483 G / L
Monograph: SODIUM LACTATE